Treatment strategies in relation to drug action.
Muggia
F M
FM
McVie
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D005047:Etoposide / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009369:Neoplasms / Q000201:enzymology; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*
D005047:Etoposide; D013713:Teniposide; D004250:DNA Topoisomerases, Type II; D011034:Podophyllotoxin